PGNY (Progyny) Tariff Resilience Score: 8/10 (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PGNY Progyny Inc PGNY
93 GF Score
Price $26.12
GF Value $28.84
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Progyny Tariff Resilience Score?

Progyny PGNY -0.97% 93 Tariff Resilience Score is 8 as of Aug. 27, 2026. GuruFocus rates PGNY with a GF Score™ of 93/100 and a GF Value™ of $28.84 (Fairly Valued). The stock has 2 warning signs investors should review. Among 18 Healthcare Plans companies, Progyny ranks better than 61.11% on this metric.

Progyny has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Progyny has Progyny Inc primarily operates in the healthcare services sector, which is less exposed to international trade tariffs. Its supply chain is mostly domestic, reducing vulnerability to tariffs. The company has limited exposure to manufacturing and international trade, making it resilient to tariff changes.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Progyny might have Highly Resilient.

Progyny  (NAS:PGNY) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Progyny Tariff Resilience Score Related Terms

PGNY vs CLOV, ALHC, PFHO: Tariff Resilience Score Comparison

For the Healthcare Plans subindustry, Progyny's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Progyny Tariff Resilience Score vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Progyny's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Progyny's Tariff Resilience Score falls into.


PGNY
93GF Score
Progyny Inc PGNY
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Progyny (PGNY) has a Tariff Resilience Score of 8 as of Aug. 27, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Progyny ranks #7 out of 18 companies in the Healthcare Plans industry, placing it in the top 38.9%.
Is Progyny's Tariff Resilience Score too high?
Progyny's current Tariff Resilience Score is 8. The Healthcare Plans industry median Tariff Resilience Score is 8.00. Progyny's value of 8 is 0% at this industry median. Based on the distribution chart, Progyny ranks #7 out of 18 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Progyny has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Progyny's Tariff Resilience Score compare to CLOV and ALHC?
According to the Healthcare Plans industry distribution chart, Progyny ranks #7 out of 18 companies for Tariff Resilience Score. This puts Progyny in the upper half of its industry. The industry median Tariff Resilience Score is 8.00. Progyny's value of 8 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Plans company?
The median Tariff Resilience Score among Healthcare Plans companies is 8.00, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Progyny's current Tariff Resilience Score of 8 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Healthcare Plans industry, the median Tariff Resilience Score is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Progyny's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Progyny stock overvalued right now?
Based on GuruFocus' analysis, Progyny (PGNY) is currently considered Fairly Valued. The stock's GF Value™ is $28.84, compared to a current price of $26.12 — trading 9.4% below its estimated fair value. The current Tariff Resilience Score is 8 and 0% at the Healthcare Plans industry median of 8.00. Progyny's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Progyny (PGNY), the current Tariff Resilience Score is 8 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Progyny (PGNY) Overvalued in 2026?

Based on GuruFocus' analysis, Progyny stock appears to be undervalued. The current stock price of $26.12 is trading 9.4% below its estimated GF Value™ of $28.84. GuruFocus considers Progyny to be Fairly Valued.

Key valuation signals for PGNY:

  • Tariff Resilience Score: 8
  • GF Value™: $28.84 vs. price of $26.12 (9.4% below fair value)
  • GF Score™: 93/100 with 2 warning signs
  • Industry Position: 0% at the Healthcare Plans median (#7 of 18)

No single metric tells the full story. See the PGNY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Progyny Business Description

Address 1359 Broadway, New York, NY, USA, 10018
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
93GF Score

Get the complete analysis for PGNY

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.12
Price
$28.84
GF Value